What Are The Strategic Insights Behind The Neuroscience Antibodies & Assays Market Expansion To $8.62 Billion?
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Are The Future Growth Projections For The Neuroscience Antibodies & Assays Market Size?
In recent times, the market size of neuroscience antibodies and assays has seen a significant expansion. The market, which is projected to surge from $4.52 billion in 2024 to $5.03 billion in 2025, is predicted to have a compound annual growth rate (CAGR) of 11.4%. Factors contributing to this increase during the historical period include research financing, drug exploration and creation, neurodegenerative illnesses, government programs, and personalized treatment plans.
In the forthcoming years, the neuroscience antibodies & assays market is projected to witness accelerated growth, with its size expected to reach $8.62 billion in 2029, growing at a compound annual growth rate (CAGR) of 14.4%. The growth during the envisioned period is anticipated to be a result of contributions from various factors such as collaborations, telemedicine’s role in neurology, educational initiatives and training, biomarker-oriented therapies, and a focus on neuroimmunology. Microrna and non-coding rna assays, digital pathology, advancements in imaging-compatible assays, single-cell analysis, and 3D organoid models are among the major trends foreseen for the market during this period.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7548&type=smp
Which Demand Drivers Are Strengthening The Neuroscience Antibodies & Assays Market?
The global escalation in neurological illness cases is foreseen to catalyze the growth of the neuroscience antibodies & assays market. A surge in neurological disorders like epilepsy, Alzheimer’s, dementia, and others, which affect the nervous system, underpins an increasing demand for more extensive research and development for disease treatments. This is where the role of antibodies and assays becomes significant—they are utilized in research and development to explore the development, systems, structure and function, and the disorders and degeneration of the nervous system. As such, the rise in neurological illness cases propels the growth of the neuroscience antibodies & assays market. For instance, data from May 2024 from the Centers for Disease Control and Prevention, a US-based federal agency, indicated that during 2021 and 2022, about 2.9 million U.S. adults aged 18 and older disclose active epilepsy. The Alzheimer’s Association, a US-based non-profit association, revealed that as of 2022, 6.5 million individuals in the US suffer from Alzheimer’s disease. Consequently, the global rise in neurological illnesses is accelerating the advancement of the neuroscience antibodies and assays market.
What Segmentation Insights Are Provided In The Neuroscience Antibodies & Assays Market Research?
The neuroscience antibodies & assaysmarket covered in this report is segmented –
1) By Product: Consumables, Instruments
2) By Technology: Molecular Diagnostics, Clinical Chemistry, Immunoassays Or Immunochemistry, Others Technologies
3) By Application: In Vitro Diagnostics, Research, Drug Discovery
4) By End User: Hospitals And Diagnostics Centers, Academic And Research Institutes, Pharmaceutical And Biotechnology Companies
Subsegments:
1) By Consumables: Antibodies, Assay Kits, Assay Kits
2) By Instruments: Spectrophotometers, Microplate Readers, Flow Cytometers, Western Blotting Systems, Imaging Systems, Automated Workstations
Which Notable Trends Are Transforming The Neuroscience Antibodies & Assays Market Outlook?
A significant trend growing in prominence in the neuroscience antibodies and assays market is the development of new technologies. Major market players are launching cutting-edge technologies like NeuroNexus Summa Framework technology to maintain their market standing. For example, in February 2022, NeuroNexus Technologies, an American firm specializing in neural interface products and technologies unveiled the NeuroNexus Summa Framework. This offering has been designed to accommodate both seasoned electrophysiologists and life science researchers seeking to seamlessly integrate electrical signal read-outs from biological cells and tissues into their research processes.
Which Firms Are Driving Innovation Within The Neuroscience Antibodies & Assays Market?
Major companies operating in the neuroscience antibodies & assays market include Abcam plc, BioLegend Inc., Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Merck KGaA, Rockland Immunochemicals Inc., GenScript Biotech Corporation, Santa Cruz Biotechnology Inc., Wak-Chemie Medical GmbH, Epitope Diagnostics Inc., Agilent Technologies, Bio-Techne Corporation, Creative Diagnostics, Enzo Life Sciences Inc., Jackson ImmunoResearch Laboratories Inc., Novus Biologicals LLC, OriGene Technologies Inc., Proteintech Group Inc., R&D Systems Inc., RayBiotech Inc., StressMarq Biosciences Inc., Synaptic Systems GmbH, Tocris Bioscience, Alomone Labs Ltd., AnaSpec Inc., Antibodies.com, Antibody Solutions, Arbor Assays, Uscn Life Science Inc., Zymo Research Corp., AAT Bioquest Inc., Abbexa Ltd., ACROBiosystems Inc., Active Motif Inc., AdipoGen Life Sciences, Advanced Targeting Systems Inc., AgriSera AB
Access The Complete Report Here:
Which Regional Markets Are Emerging As Key Hubs For The Neuroscience Antibodies & Assays Market?
North America was the largest region in the neuroscience antibodies & assays market in 2024. The regions covered in the neuroscience antibodies & assays market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=7548&type=smp
Browse Through More Reports Similar to the Global Neuroscience Antibodies & Assays Market 2025, By The Business Research Company
Neurology Devices Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/neurology-devices-global-market-report
Neurodegenerative Disorder Therapeutic Global Market Report 2025
Neurophysiology Devices And Equipment Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
